Recruiting Clinical Trials

Displaying 1 - 10 of 49 result(s)
Study Title Condition Phase Location
Extension to the Study of Efficacy of CDZ173 in Patients With APDS/PASLI
  • Activated PI3Kdelta Syndrome (APDS); PASLI Disease
  • Phase 2
  • Phase 3
  • Country: 
    United States
  • Country: 
    Belarus
  • Country: 
    Czechia
  • Country: 
Study of Efficacy and Safety of Two Secukinumab Dose Regimens in Subjects With Moderate to Severe Hidradenitis Suppurativa (HS)
  • Hidradenitis Suppurativa
  • Phase 3
  • Country: 
    United States
  • Country: 
    Argentina
  • Country: 
    Belgium
  • Country: 
Study the Efficacy and Safety of VAY736 and CFZ533 in SLE Patients
  • Systemic Lupus Erythematosus (SLE)
  • Phase 2
  • Country: 
    Argentina
  • Country: 
    Australia
  • Country: 
    China
  • Country: 
Study of Efficacy of CDZ173 in Patients With APDS/PASLI
  • Common Variable Immunodeficiency (CVID) More Specifically Activated PI3Kdelta Syndrome (APDS) p110delta-activating Mutation Causing Senescent T Cells
  • Lymphadenopathy and Immunodeficiency (PASLI)
  • Phase 2
  • Phase 3
  • Country: 
    United States
  • Country: 
    Belarus
  • Country: 
    Czechia
  • Country: 
Study of Efficacy and Safety of Asciminib in Combination With Imatinib in Patients With Chronic Myeloid Leukemia in Chronic Phase (CML-CP)
  • CML
  • Chronic Myelogenous Leukemia
  • Leukemia, Myeloid Chronic
  • Hematologic Diseases
  • Phase 2
  • Country: 
    United States
  • Country: 
    Australia
  • Country: 
    Austria
  • Country: 
Activity, Safety and Pharmacokinetics in Pediatric Subjects With Moderate and Severe Chronic Graft vs. Host Disease After Allogeneic Stem Cell Transplant
  • Graft vs Host Disease
  • Phase 2
  • Country: 
    Brazil
  • Country: 
    Czechia
  • Country: 
    India
  • Country: 
Study of Efficacy, Safety, and Tolerability of LYS006, in Patients With Mild to Moderate Ulcerative Colitis
  • Colitis, Ulcerative
  • Phase 2
  • Country: 
    United States
  • Country: 
    Bulgaria
  • Country: 
    Czechia
  • Country: 
Phase II Pediatric Study With Dabrafenib in Combination With Trametinib in Patients With HGG and LGG
  • Diffuse Astrocytoma
  • Anaplastic Astrocytoma
  • Astrocytoma
  • Oligodendroglioma, Childhood
  • Anaplastic Oligodendroglioma
  • Glioblastoma
  • Pilocytic Astrocytoma
  • Giant Cell Astrocytoma
  • Pleomorphic Xanthoastrocytoma
  • Anaplastic Pleomorphic Xanthoastrocytoma
  • Angiocentric Glioma
  • Chordoid Glioma of Third Ventricle
  • Gangliocytoma
  • Ganglioglioma
  • Anaplastic Ganglioglioma
  • Dysplastic Gangliocytoma of Cerebrellum
  • Desmoplastic Infantile Astrocytoma and Ganglioglioma
  • Papillary Glioneuronal Tumor
  • Rosette-forming Glioneurona Tumor
  • Central Neurocytoma
  • Extraventricular Neurocytoma
  • Cerebellar Iponeurocytoma
  • Phase 2
  • Country: 
    United States
  • Country: 
    Argentina
  • Country: 
    Australia
  • Country: 
Study to Assess the Efficacy and Safety of Brolucizumab 6mg Compared to Aflibercept 2 mg in a Treat-to-control Regimen (TALON)
  • Age-related Macular Degeneration
  • Macular Degeneration
  • Wet Macular Degeneration
  • Retinal Degeneration
  • Retinal Diseases
  • Eye Diseases
  • Phase 3
  • Country: 
    United States
  • Country: 
    Argentina
  • Country: 
    Australia
  • Country: 
Study of Efficacy and Safety of MBG453 in Combination With Azacitidine in Subjects With Intermediate, High or Very High Risk Myelodysplastic Syndrome (MDS) as Per IPSS-R, or Chronic Myelomonocytic Leukemia-2 (CMML-2)
  • Myelodysplastic Syndromes
  • Leukemia, Myelomonocytic, Chronic
  • Phase 3
  • Country: 
    United States
  • Country: 
    Australia
  • Country: 
    Austria
  • Country: